There are limited data describing the experience of radiofrequency (RF) vs. cryoballoon (CB) ablation for atrial fibrillation (AF) among elderly patients in the United States. We conducted a retrospective analysis of patients ≥75 years of age undergoing index RF vs. CB ablation between January 2014 and May 2020 at our center. The choice of ablation technique was left to the operator's discretion. Major complications and efficacy, defined as freedom from any atrial tachyarrhythmia (ATA) lasting ≥30 s after one year of follow-up, were assessed in patients with index RF vs. CB ablation. In our cohort of 186 patients, the median age was 78 (76–81) years, 54.8% were men, and 39.2% had persistent AF. The median CHA2DS2-VASc score was 4 (3–4), while the median duration of AF was 3 (1–7) years. The majority (n = 112, 60.2%) underwent RF ablation. The median procedure time was significantly lower in CB group (197 vs 226.5 min, p=<0.01). The incidence of complications was similar in the two sub-groups (RF: 1.8% vs. CB: 2.7%, p = 0.67). Similarly, arrhythmia-free survival rate on antiarrhythmic drugs at 1-year follow-up remained statistically comparable (63.4% vs. 68.9%, p = 0.33) between patients receiving RF vs. CB ablation. The safety and efficacy of RF vs. CB ablation for AF remained comparable in our cohort of patients older than 75 years. CB ablation was associated with a shorter procedure time.
11 December 2024 in Catheterization and Cardiovascular Interventions
The 5-fluorouracil (5-FU) component of 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) chemotherapy is a known cause of coronary vasospasm. Diagnosis can be difficult, often leading to interruption of chemotherapy. A 53-year-old man with a history of colorectal cancer developed new-onset angina after initiation of FOLFOX chemotherapy. He underwent a left heart catheterization, coronary functional testing (CFT), and acetylcholine (ACh) provocation. ACh provocation elicited similar angina, consistent with microvascular vasospasm. This prompted initiation of calcium-channel blockers and adjustments to chemotherapy administration, preventing further angina. CFT with ACh provocation should be considered in patients undergoing chemotherapy with 5-FU. As 5-FU coronary vasospasm is often transient, ACh provocation can identify patients who would benefit from calcium-channel blockers and changing 5-FU administration from continuous to bolus dosing. This case highlights the utility of CFT in identifying and guiding treatment in suspected cases of 5-FU-associated coronary vasospasm.